Country: Canada
Language: English
Source: Health Canada
TOBRAMYCIN (TOBRAMYCIN SULFATE)
SANDOZ CANADA INCORPORATED
J01GB01
TOBRAMYCIN
40MG
SOLUTION
TOBRAMYCIN (TOBRAMYCIN SULFATE) 40MG
INTRAMUSCULAR
10X2ML 1X30ML
Prescription
AMINOGLYCOSIDES
Active ingredient group (AIG) number: 0110230001; AHFS:
APPROVED
1999-11-10
_Tobramycin Injection USP _ _ _ _Page 1 of 25 _ PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR TOBRAMYCIN INJECTION USP (Tobramycin as Tobramycin Sulfate) 10 mg/mL and 40 mg/mL Antibiotic Sandoz Canada Inc. Date of Revision: July 17, 2017 145 Jules-Léger Boucherville, QC J4B 7K8 Control number: 201425 _Tobramycin Injection USP _ _ _ _ Page 2 of 25 _ PR TOBRAMYCIN INJECTION USP (Tobramycin as Tobramycin Sulfate) 10 mg/mL and 40 mg/mL Antibiotic ACTION AND CLINICAL PHARMACOLOGY The bactericidal activity of tobramycin, like that of other aminoglycosides, is accomplished by specific inhibition of normal protein synthesis in susceptible bacteria. However, at the present time, very little is known about the specific site(s) of this action. It is thought that inhibition of synthesis is due to an action on ribosomes that, in turn, causes bacterial misreading of messenger RNA. INDICATIONS Tobramycin Injection USP may be indicated for the treatment of the following infections when caused by susceptible organisms: septicemia, complicated and recurrent urinary tract infections, lower respiratory infections, serious skin and soft tissue infections including burns and peritonitis and central nervous system infections caused by organisms resistant to antibiotics usually considered efficacious in these infections. Tobramycin is usually active against most strains of the following organisms _in vitro_ and in clinical infections: _Pseudomonas aeruginosa _ _Proteus_ sp. (indole-positive and indole-negative), including _Proteus mirabilis, _ _Morganella morganii, Providencia rettgeri_, and _Proteus vulgaris _ _Escherichia coli _ _Klebsiella-Enterobacter-Serratia_ group _Citrobacter_ sp. _Providencia_ sp. _Staphylococci_, including _Staphylococcus aureus_ (coagulase-positive and coagulase- negative) Tobramycin Injection USP may be considered in serious staphylococcal infections when penicillin or other potentially less toxic drugs are contraindicated and when bacterial susceptibility testing Read the complete document